Oncolytic Virus (OV) Cancer Therapy Market in United States, United Kingdom– Market Outlook, Market Assessment and Market Forecast (2023-2030)

Oncolytic Virus (OV) – Report Overview

Pacific Business Consulting’s “Oncolytic Virus (OV) Cancer Therapy Market – Market Outlook, Market Assessment and Market Forecast (2023-2030)” report offers a comprehensive exploration of Oncolytic Virus Cancer Therapy, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Eight Major Markets (8MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, and China.

Oncolytic viruses represent a form of immunotherapy that utilizes viruses to infect and eliminate cancer cells. These viruses, either naturally occurring or genetically engineered, have the ability to preferentially replicate in tumor cells, hindering tumor growth. Oncolytic Virus Therapies involve the use of viruses that can replicate themselves to selectively kill cancer cells. To be considered oncolytic viruses (OVs), they must possess certain features, including non-pathogenicity, the ability to target and kill cancer cells, and the capacity for genetic engineering to express tumor-killing factors.

Oncolytic viruses have emerged as a potent anticancer strategy with multifunctional characteristics applicable to cancer diagnosis and treatment. Their versatility suggests promising prospects as cancer therapeutics, especially when combined with other therapies such as radiotherapy, chemotherapy, and immunotherapy.

Currently, only two oncolytic virus therapies are approved: IMLYGIC (Talimogene laherparepvec/T-VEC; Amgen), approved in the US and Europe in 2015, and DELYTACT (teserpaturev/G47∆; Daiichi Sankyo), approved in Japan in 2021. The Oncolytic Virus Therapies market is poised to undergo changes in the coming years due to improved patient outcomes, the treatment of cold tumors, a rich emerging pipeline, and convenient production and administration methods. These factors are expected to expand the market size, allowing drug manufacturers to penetrate the market further.

Companies and academics in the Oncolytic Virus Therapies field are actively assessing challenges and exploring opportunities to influence research and development. Therapies under development focus on novel approaches to treat and improve disease conditions. Major companies involved in Oncolytic Virus Therapies are developing novel products to enhance the treatment landscape. The launch of emerging therapies is anticipated to significantly impact the Oncolytic Virus Therapies market.

Leading Oncolytic Virus Cancer companies in the market include Amgen, Daiichi Sankyo, Targovax, Replimune, DNAtrix, SillaJen, Genelux Corporation, Candel Therapeutics, Treovir, Lokon Pharma AB, Istari Oncology, and CG Oncology.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the Oncolytic Virus (OV) Cancer Therapy market. It also delves into the analysis of present and prospective market competition within the global Oncolytic Virus (OV) Cancer Therapy market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the Oncolytic Virus (OV) Cancer Therapy market across the 8MM (Eight Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 8MM Oncolytic Virus (OV) Cancer Therapy market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

Please note that detailed pipeline analysis can be provided along with the standard scope to assist you in developing and designing your in-licensing and out-licensing strategies. This includes a review of pipeline products and technologies, along with identifying companies with the most robust pipeline.

1. Executive Summary: Oncolytic Virus (OV) Cancer Therapy
   • Global Market Outlook: Oncolytic Virus (OV) Cancer Therapy
2. Competitive Intelligence Analysis; Oncolytic Virus (OV) Cancer Therapy
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Oncolytic Virus (OV) Cancer Therapy: Key Marketed Products Profile – Major Approved Products
   • Product Profile
   • Regulatory Milestones
   • Safety and Efficacy
   • Clinical Development
7. Oncolytic Virus (OV) Cancer Therapy: Promising Pipeline Candidates – Major Products in Late Stage of Development
   • Product Description
   • Safety and Efficacy
   • Research and Development
8. Regulatory Landscape
9. Oncolytic Virus (OV) Cancer Therapy: Eight Major Market (8MM) – Market Analysis
   • Historical Market Analysis (US$ million), 2020-2022
   • Current and Future Market Projections (US$ million), 2023-2030
10. S. Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
11. K. Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
12. Germany Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
13. France Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
14. Italy Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
15. Spain Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
16. Japan Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
17. China Oncolytic Virus (OV) Cancer Therapy – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
    • Current and Future Market Projections (US$ million), 2023-2030
18. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

19. Assumptions and Acronyms Used
20. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
21. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, and China

Copyrights and Disclaimer